Samsung Biologics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	148,851	391,222	367,937	890,820	47,410
Short-Term Investments	1,307,175	907,350	1,688,338	2,204,212	473,985
Trading Asset Securities	-	-	-	98,506	850,040
Cash & Short-Term Investments	1,456,026	1,298,572	2,056,276	3,193,537	1,371,435
Cash Growth	12.13%	-36.85%	-35.61%	132.86%	60.96%
Accounts Receivable	780,094	1,246,732	-	-	0
Receivables	780,094	1,246,732	-	-	0
Inventory	2,128,164	2,818,276	2,641,368	2,375,819	1,012,871
Prepaid Expenses	-	-	26,830	23,201	8,579
Other Current Assets	44,082	154,538	797,513	865,099	430,291
Total Current Assets	4,408,367	5,518,118	5,521,988	6,457,657	2,823,175
Property, Plant & Equipment	6,037,532	5,837,482	4,342,424	3,871,452	2,227,687
Long-Term Investments	78,325	59,605	47,435	38,110	2,661,499
Goodwill	-	-	1,677,608	1,677,608	-
Other Intangible Assets	60,193	5,565,303	1,580,423	1,541,850	32,172
Long-Term Accounts Receivable	-	-	0	-0	0
Long-Term Deferred Tax Assets	132,837	165.09	-	-	-
Long-Term Deferred Charges	-	-	2,574,057	2,741,848	-
Other Long-Term Assets	343,489	355,623	302,236	253,524	225,477
Total Assets	11,060,742	17,336,296	16,046,197	16,582,050	7,970,011
Accounts Payable	486,387	1,511,088	201,709	59,616	32,251
Accrued Expenses	-	-	281,317	207,437	74,322
Short-Term Debt	-	-	654,500	582,783	50,000
Current Portion of Long-Term Debt	319,713	327,000	733,405	556,017	109,855
Current Portion of Leases	7,258	138,594	144,031	142,247	7,537
Current Income Taxes Payable	355,700	375,388	191,212	223,299	110,174
Current Unearned Revenue	161,849	99,482	399,818	432,680	-
Other Current Liabilities	1,202,010	1,401,636	1,551,870	1,977,462	723,156
Total Current Liabilities	2,532,917	3,853,188	4,157,861	4,181,542	1,107,295
Long-Term Debt	599,012	1,012,757	239,783	965,090	1,114,684
Long-Term Leases	1,112	7,889	137,614	267,896	10,671
Long-Term Unearned Revenue	377,588	477,371	-	-	-
Pension & Post-Retirement Benefits	-	-	5,117	-	-
Long-Term Deferred Tax Liabilities	-	-	1,184,420	1,214,216	487,712
Other Long-Term Liabilities	99,002	1,080,415	490,910	968,833	258,547
Total Liabilities	3,609,631	6,431,620	6,215,705	7,597,576	2,978,909
Common Stock	115,727	177,935	177,935	177,935	165,413
Additional Paid-In Capital	3,391,926	5,663,111	5,663,111	5,663,111	2,487,313
Retained Earnings	6,870,961	5,086,609	4,003,293	3,145,601	2,347,187
Treasury Stock	-92,013	-	-	-	-
Comprehensive Income & Other	-2,835,491	-22,979	-13,847	-2,173	-8,811
Shareholders' Equity	7,451,111	10,904,676	9,830,492	8,984,474	4,991,102
Total Liabilities & Equity	11,060,742	17,336,296	16,046,197	16,582,050	7,970,011
Total Debt	927,094	1,486,239	1,909,333	2,514,033	1,292,747
Net Cash (Debt)	528,931	-187,668	146,943	679,504	78,688
Net Cash Growth	-	-	-78.38%	763.54%	17.19%
Net Cash Per Share	-	-	3174.34	14965.87	1828.54
Filing Date Shares Outstanding	54.52	46.29	46.29	46.29	43.03
Total Common Shares Outstanding	54.52	-	46.29	46.29	43.03
Working Capital	1,875,449	1,664,929	1,364,127	2,276,115	1,715,881
Book Value Per Share	136675.36	235568.21	212363.16	194087.06	115982.76
Tangible Book Value	7,390,917	5,339,373	6,572,461	5,765,016	4,958,931
Tangible Book Value Per Share	135571.23	115343.78	141981.56	124538.73	115235.15
Land	-	-	141,065	141,065	-
Buildings	-	-	1,943,694	1,376,222	832,519
Machinery	-	-	2,525,344	1,811,982	1,380,919
Construction In Progress	-	-	202,411	825,199	583,360

Source: S&P Global Market Intelligence. Standard template. Financial Sources.